Cargando…

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia

BACKGROUND: The anti-interleukin-6 receptor monoclonal antibody tocilizumab has been proposed as a treatment for COVID-19 pneumonia although the efficacy remains unknown. METHODS: Patients with COVID-19 confirmed by nasal swab PCR for SARS-CoV-2 who were admitted to Stony Brook University Hospital i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisher, Matthew, Marcos, Luis, Monteforte, Melinda, Taub, Erin, Go, Roderick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776316/ http://dx.doi.org/10.1093/ofid/ofaa439.757

Ejemplares similares

Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients
por: Fisher, Matthew J., et al.
Publicado: (2021)

563. Experience of a Private Hospital in the Treatment of COVID-19 Pneumonia in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2021)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia
por: Warner, Adam, et al.
Publicado: (2021)

640. A Retrospective Assessment of the Effects of Cefiderocol in Patients with Multidrug-resistant Gram-negative Bacterial Infections
por: Sajib, Monirul I, et al.
Publicado: (2022)

229. The Role of Antimicrobial Stewardship Program on Appropriate Use, Dose, and Duration of Vancomycin Treatment
por: Kaplun, Olga, et al.
Publicado: (2018)

304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients
por: de Novales, Francisco Javier Membrillo, et al.
Publicado: (2021)

562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports
por: iqbal, Fatima, et al.
Publicado: (2021)

566. Tocilizumab: A Friend or a Foe in COVID-19 Management?
por: Hernandez, Jarelys M, et al.
Publicado: (2020)

PS 339-563
Publicado: (2005)

563. Association Between Chlorhexidine Gluconate Concentrations and Resistant Bacterial Bioburden on Skin
por: Nadimpalli, Gita, et al.
Publicado: (2019)

562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
por: Norman, Sarah, et al.
Publicado: (2020)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

564. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19
por: Colgrove, Robert, et al.
Publicado: (2020)

565. Tocilizumab Use in COVID-19: Act(emra) to Inhibit Intubation and Decompensation
por: Willner, Debra M, et al.
Publicado: (2020)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

Poster Sessions 499–563
Publicado: (2001)

P563: NOVEL GENES EXHIBITING FUNCTIONAL RELEVANCE IN KOREAN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
por: Kim, Jiyeon, et al.
Publicado: (2023)

554. Early Clinical Outcomes with Tocilizumab for Covid-19: A Two-Center Retrospective Study
por: Smoke, Steven, et al.
Publicado: (2020)

760. A Silent Threat: Seroprevalence of Chagas Disease in Latin Americans Living in Long Island, New York
por: Michelen, Yamil E, et al.
Publicado: (2020)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
por: Macatangay, M.V.R., et al.
Publicado: (2022)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

Clinical Outcome of Cefiderocol for Infections with Carbapenem-Resistant Organisms
por: Sajib, Monirul I., et al.
Publicado: (2023)

563 Fire safety in homeless encampments
por: Rehou, Sarah, et al.
Publicado: (2022)

563. Not Your Parent’s Epidemic: New HIV Diagnoses and the New Patient Cascade of Care in the Bronx, New York
por: Mogollon, Jaime Eduardo, et al.
Publicado: (2018)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

563 Measurement of Long-acting Natriuretic Peptide (Lanp) in Exacerbation of Asthma
por: Alkhalil, Michel, et al.
Publicado: (2012)

POS-563 PREVALENCE OF COVID 19 IN A HOSPITAL HEMODIALYSIS UNIT
por: Begoña Boldoba, N., et al.
Publicado: (2021)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

563. Mycoplasma genitalium with Fluoroquinolone Resistance: Design and Development of a Multiplex Real-Time PCR Assay for Detection and Differentiation
por: Alabyev, Boris, et al.
Publicado: (2023)

53. Incidence of Bloodstream Infections and Outcomes in Patients with Severe COVID-19 Pneumonia
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19
por: Maguire, Christina, et al.
Publicado: (2022)

Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis
por: Castellano, Giuseppe, et al.
Publicado: (2020)

76. Effect of Early Administration of Systemic Corticosteroids on Outcomes in Patients with COVID-19 Pneumonia
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hffa38r8p4dp85v4d3g16ueid2